U.S. Bioscience - Ownership and Business Overview

Life ScienceCompany

U.S. Bioscience Ownership

Who owns U.S. Bioscience?

U.S. Bioscience is owned by MedImmune. It was acquired on September 23, 1999.

U.S. Bioscience Business Overview

Where is U.S. Bioscience headquartered?

U.S. Bioscience is headquartered in West Conshohocken, Pennsylvania.

How many employees does U.S. Bioscience have?

U.S. Bioscience has 148 employees.

What sector is U.S. Bioscience in?

U.S. Bioscience is a life science company.

When was U.S. Bioscience founded?

U.S. Bioscience was founded in 1987.

Life Science M&A Summary in 1999

Out of 60 sectors in the Mergr database, life science ranked 20 in number of deals in 1999. The largest life science acquisition in 1999 was SUGEN - which was acquired by Pharmacia for $650M.

Join Mergr to view all 21 acquisitions of life science companies in 1999, including 8 acquisitions by private equity firms, and 13 by strategics.

U.S. Bioscience, Inc.

100 Front Street One Tower Bridge Suite 400,
West Conshohocken, Pennsylvania 19428
United States,
(610) 832-0570

U.S. Bioscience, Inc. engages in developing drugs to treat cancer and AIDS. U.S. Bioscience's product portfolio includes Ethyol, which is approved for the reduction of cumulative kidney toxicity associated with repeated chemotherapy in patients with advanced ovarian cancer and non-small-cell lung cancer.


 Subscribe to unlock this and 208,528
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.